Endpoint surrogacy in oncology Phase 3 randomised controlled trials

Endpoint surrogacy is an important concept in oncology trials. Using a surrogate endpoint like progression-free survival as the primary endpoint—instead of overall survival—would lead to a potential faster drug approval and therefore more cancer patients with an earlier opportunity to receive the ne...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Zhang, Jianrong, Pilar, Meagan R., Wang, Xiaofei, Liu, Jingxia, Pang, Herbert, Brownson, Ross C., Colditz, Graham A., Liang, Wenhua, He, Jianxing
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Editorial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7403397/
https://ncbi.nlm.nih.gov/pubmed/32451466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0896-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados